8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2018 / Intervention trial with matched historical controls
Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.
Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594
2018 / Secondary analysis of a trial (before-and-after / paired analysis)
In a secondary analysis of a trial, 31 overweight and obese adults with LDL cholesterol >100 mg/dL consumed a defined plant-based diet for 4 weeks. Significant reductions were observed for serum Lp(a) (-32.0 ± 52.3 nmol/L, P = 0.003), apolipoprotein B (-13.2 ± 18.3 mg/dL, P < 0.0005), LDL particles (-304.8 ± 363.0 nmol/L, P < 0.0005), and small-dense LDL cholesterol (-10.0 ± 9.2 mg/dL, P < 0.0005). Significant reductions were also seen in IL-6, total white blood cells, Lp-PLA2, hs-CRP, and fibrinogen (all P ≤ 0.004).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 30014498
2018 / Randomized controlled trial
A trial randomized 46 overweight and obese women to an isoenergetic diet either supplemented with or free of baru almonds for 8 weeks. Compared with the control diet, consuming baru almonds reduced waist circumference by 2.45 cm (95% CI, -3.90 to -0.23; P = 0.03) and cholesteryl ester transfer protein expression by 0.23 mcg/mL (95% CI, -1.24 to -0.08; P = 0.03). High-density lipoprotein concentrations also increased by 4.82 mg/dL (95% CI, 0.03 to 8.88; P = 0.04).
de Souza RGM, Gomes AC, de Castro IA, et al. Nutrition, 2018. PMID 30086484
2018 / Randomized, placebo-controlled trial
Researchers randomly assigned 15,480 patients with diabetes and no evidence of atherosclerotic cardiovascular disease to receive daily 1-g capsules of n-3 fatty acids or an olive oil placebo. Over a mean follow-up of 7.4 years, serious vascular events occurred in 8.9% of the fatty acid group and 9.2% of the placebo group (rate ratio, 0.97; 95% CI, 0.87 to 1.08; P=0.55). The composite outcome of a serious vascular event or revascularization occurred in 11.4% and 11.5%, respectively (rate ratio, 1.00; 95% CI, 0.91 to 1.09), and all-cause death occurred in 9.7% versus 10.2% (rate ratio, 0.95; 95% CI, 0.86 to 1.05).
ASCEND Study Collaborative Group, Bowman L, Mafham M, et al. N Engl J Med, 2018. PMID 30146932
2018 / Randomized crossover trial
In a randomized crossover study involving 27 overweight volunteers, researchers compared diets enriched with walnuts or almonds differing in fatty acid composition. The walnut diet significantly improved flow-mediated dilation (p = 0.004) and reduced sVCAM levels (p = 0.009). The almond diet significantly lowered sVCAM (p = 0.004) and showed a trend toward improving flow-mediated dilation (p = 0.06), with no significant differences between the two diets.
Bhardwaj R, Dod H, Sandhu MS, et al. Indian Heart J, 2018. PMID 30170643
2018 / Randomized crossover trial
A randomized, crossover trial in 63 non-diabetic pre-hypertensive volunteers evaluated the effects of 4-week diets with ancient wheat products (organic KAMUT khorasan) versus modern wheat products. Ancient wheat intake resulted in significant improvements in triglycerides (-9.8% vs. baseline, -14.5% vs. modern wheat), fasting plasma glucose (-4.3% vs. baseline, -31.6% vs. modern wheat), diurnal SBP (-3.1% vs. baseline, -30.2% vs. modern wheat), nocturnal SBP (-3.2% vs. baseline, -36.8% vs. modern wheat), and pulse volume change (+4.2% vs. baseline, +2.3% vs. modern wheat) (all p < 0.05). The authors concluded that replacing modern wheat with ancient wheat might exert a mild improvement in 24-hour SBP and endothelial reactivity.
Cicero AFG, Fogacci F, Veronesi M, et al. Nutrients, 2018. PMID 30400372
2018 / Randomized controlled trial
An open-label randomized trial assigned 100 participants with coronary artery disease to 8 weeks of a vegan diet or an American Heart Association diet. The vegan diet resulted in a 32% lower high-sensitivity C-reactive protein level compared to the AHA diet (adjusted β, 0.67; 95% CI, 0.47-0.94; P = 0.02). Reductions in body mass index, waist circumference, and glycemic control markers did not differ significantly between groups.
Shah B, Newman JD, Woolf K, et al. J Am Heart Assoc, 2018. PMID 30571591
2018 / Randomized controlled trial
Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).
Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861
2017 / Randomized, double-blinded crossover trial
In a randomized, double-blinded crossover trial, 21 patients with type 2 diabetes consumed products made from organic ancient khorasan wheat or modern organic control wheat for 8 weeks each, separated by an 8-week washout. The metabolic risk profile improved only after the khorasan intervention, with mean reductions in total cholesterol (-3.7%), LDL cholesterol (-3.4%), insulin (-16.3%), and blood glucose (-9.1%). Khorasan wheat also significantly reduced reactive oxygen species, VEGF, and interleukin-1ra, and increased total antioxidant capacity (+6.3%), whereas modern wheat produced no significant differences from baseline.
Whittaker A, Dinu M, Cesari F, et al. Eur J Nutr, 2017. PMID 26853601
2017 / Repeated-measures crossover trial
Fifteen recreational runners completed a graded exercise protocol followed by four 15-minute treadmill economy trials at 70% of VO2max, conducted 1 hour after consuming one of three energy drinks or a placebo. Fifteen-minute systolic blood pressure was significantly lower in the placebo trials (156.93 ± 15.50) compared to the three energy drink trials (163.87 ± 13.30, 166.47 ± 13.71, and 165.00 ± 15.23). No significant differences were observed for diastolic blood pressure, heart rate, VO2, or rating of perceived exertion.
Peveler WW, Sanders GJ, Marczinski CA, et al. J Strength Cond Res, 2017. PMID 27386963
2017 / Monocentric, randomized, parallel-group, placebo-controlled trial
A 4-month randomized, parallel-group, placebo-controlled trial evaluated daily apple consumption in 250 mildly hypercholesterolaemic healthy subjects divided into five groups of 50 (28 men and 22 women per group). Four groups received one apple per day (Red Delicious, Granny Smith, Fuji, or Golden Delicious), while the fifth group consumed two Annurca apples per day. Annurca apple consumption reduced total cholesterol by 8.3% and LDL cholesterol by 14.5%, and increased HDL cholesterol by 15.2% (all P < 0.001), achieving the most significant outcome among the tested cultivars.
Tenore GC, Caruso D, Buonomo G, et al. J Sci Food Agric, 2017. PMID 27571713
2017 / Randomized controlled trial
A randomized, double-blind trial gave 44 overweight or obese adults either yeast beta-glucan (up to 954 mg daily) or placebo for six weeks. Compared to placebo, beta-glucan significantly reduced waist circumference (p = 0.037), blood pressure (p = 0.006), and IL-6 at week six (p = 0.005), while increasing IL-10 (p < 0.001). No significant differences appeared in lipid profiles, liver and kidney markers, or nutrient intake.
Mosikanon K, Arthan D, Kettawan A, et al. J Diet Suppl, 2017. PMID 27715351
2017 / Crossover trial
Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.
Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549
2017 / Randomized crossover trial
A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).
Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205
2017 / Randomized, placebo-controlled, double-blind parallel trial
A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.
Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820
2017 / Randomized controlled crossover trial
In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.
Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779
2017 / Double-blind, parallel, randomized placebo-controlled trial
A double-blind, parallel, randomized placebo-controlled trial examined the effects of eight weeks of daily supplementation with six capsules of fruit and vegetable juice concentrate or placebo in 56 overweight and obese adults aged ≥40 years. Following consumption of the juice concentrate, total cholesterol, LDL cholesterol, and plasma TNFα decreased and total lean mass increased, with no change in the placebo group. In participants with high baseline systemic inflammation (serum CRP ≥3.0 mg/mL, n = 16), these effects were greater, though plasma CRP remained unchanged. The concentrate also altered the expression of genes involved in lipogenesis, NF-κB, and AMPK signalling pathways, such as PMVK, ZFAND5, and CAB39.
Williams EJ, Baines KJ, Berthon BS, et al. Nutrients, 2017. PMID 28208713
2017 / Randomized crossover trial
Twelve postmenopausal women consumed 30 mL daily of virgin coconut oil or safflower oil for 28 days in a crossover trial. Virgin coconut oil significantly elevated total cholesterol (+18.2 mg/dL), LDL cholesterol (+13.5 mg/dL), and HDL cholesterol (+6.6 mg/dL), while safflower oil did not alter lipids. Both oils produced neutral changes in total-to-HDL cholesterol ratios, and interleukin-1beta decreased in all participants with detectable samples after coconut oil.
Harris M, Hutchins A, Fryda L J Med Food, 2017. PMID 28277823
2017 / Pre-post intervention study
Eleven young healthy medical students were tested at baseline and 90 minutes after consuming a 24-oz can of Monster Energy beverage. Heart rate and systolic/diastolic blood pressure did not change significantly from baseline. However, peak flow-mediated dilatation (FMD) was significantly attenuated after beverage consumption (baseline 5.9% ± 4.6% vs post-consumption 1.9% ± 2.1%; P = 0.03).
Higgins JP, Yang B, Herrin NE, et al. World J Cardiol, 2017. PMID 28289530
2017 / Randomized controlled trial
In a randomized controlled trial of 65 adults with overweight or obesity and cardiometabolic conditions, an ad libitum whole food plant-based diet was compared to usual care. At 6 months, mean BMI reduction was significantly greater in the diet group (difference: 3.9 kg m-2, 95% CI ±1, P < 0.0001). Total cholesterol reduction did not significantly differ between groups unless dropouts were excluded (difference: 0.56 mmol l-1, P = 0.05).
Wright N, Wilson L, Smith M, et al. Nutr Diabetes, 2017. PMID 28319109
2017 / Randomized crossover trial
Chronic shift workers completed two 3-day laboratory protocols simulating night work (12-hour inverted cycles; circadian misalignment) or day work (circadian alignment) in a randomized crossover design. Circadian misalignment increased 24-h hs-CRP by 11% (p < 0.0001) and increased 24-h systolic blood pressure (SBP) by 1.4 mmHg and diastolic blood pressure (DBP) by 0.8 mmHg (both p ≤ 0.038). The increase in 24-h SBP was primarily driven by an increase during wakefulness (+1.7 mmHg; p = 0.017), while the increase in 24-h DBP was mainly during sleep opportunity (+1.8 mmHg; p = 0.005).
Morris CJ, Purvis TE, Mistretta J, et al. J Biol Rhythms, 2017. PMID 28347188
2017 / Randomized controlled crossover trial
A randomized crossover study evaluated 15 healthy overweight or obese men who consumed high-fat shake meals containing either 85 g of ground peanuts or a matched control. Acute peanut intake blunted postprandial serum triglyceride levels at 120 minutes (188.9 ± 19.4 vs 197.5 ± 20.7 mg/dL) and 240 minutes (189.9 ± 24.3 vs 197.3 ± 18.4 mg/dL; both P < 0.05). Furthermore, flow-mediated dilatation decreased at 240 minutes after the control meal (-1.2% ± 0.5%, P = 0.029) but was preserved with peanuts.
Liu X, Hill AM, West SG, et al. J Nutr, 2017. PMID 28356431
2017 / Double-blind, parallel-design randomized clinical trial
The RESTORE trial randomized 66 patients aged 65 or older with peripheral artery disease to 125 mg/d resveratrol, 500 mg/d resveratrol, or placebo for 6 months. Six-month mean (SE) changes in 6-minute walk distance were 4.6 (8.1) m for the 125-mg group, -12.8 (7.5) m for the 500-mg group, and -12.3 (7.9) m for the placebo group (P = .07 for 125 mg vs placebo; P = .96 for 500 mg vs placebo). Changes in maximal treadmill walking time were 0.5 (2.3) minutes for 125 mg, -0.6 (2.1) minutes for 500 mg, and 0.4 (2.1) minutes for placebo (P = .18 and P = .12 vs placebo, respectively). The authors concluded there was no consistent evidence that resveratrol improves walking performance in this population.
McDermott MM, Leeuwenburgh C, Guralnik JM, et al. JAMA Cardiol, 2017. PMID 28403379
2017 / Randomized, double-blind crossover study
Nine healthy men completed a randomized, double-blind crossover study comparing postprandial responses over 4 hours to a low-fat high-carbohydrate (LF) meal, a high-fat low-carbohydrate (HF) meal, and an LF meal with added theobromine. Postprandial apoA-I concentrations were comparable across all three meals. Compared to the LF meal, the HF meal led to significantly lower apolipoprotein B48 curves and significantly higher triacylglycerol curves, along with smaller decreases in free fatty acids and smaller increases in glucose and insulin. Theobromine did not alter postprandial responses to the LF meal, except for an increase in the incremental area under the curve for insulin.
Smolders L, Mensink RP, Plat J Nutr Res, 2017. PMID 28438412